Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency
- Study Title
- Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)
- Teva Identifier
- TV1106-IMM-30022 | 2014-002736-13
- ClinicalTrials.gov Identifier
- NCT02410356
- Study Status
- Terminated
- Trial Condition(s)
- Growth Hormone Deficiency
- Interventions
- Drug: TV-1106 | Drug: dGH
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- April 30, 2015 - April 30, 2016
- Phase
- Phase 3
